Post Mon Apr 15, 2024 8:43 pm

2024-Coffey et al-J Immunother Cancer

"Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma"
David G Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho
J Immunother Cancer. 2024, 12, e008110
https://doi.org/10.1136/jitc-2023-008110

- no CyTOF dataset accession given